1. Catalog
  2. Nodes
  3. path(MESH:Hyperlipidemias)

path(MESH:Hyperlipidemias)

Equivalencies: 0 | Classes: 0 | Children: 0 | Explore

Entity

Name
Hyperlipidemias
Namespace
MeSH
Namespace Version
20181007
Namespace URL
https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns

Appears in Networks 1

Heme Curation v0.0.1-dev

Mechanistic knowledge surrounding heme

In-Edges 0

Out-Edges 2

path(MESH:Hyperlipidemias) decreases act(a(MESH:"Nitric Oxide Synthase")) View Subject | View Object

Mice with diabetes mellitus or hyperlipidemia have evidence of endothelial dysfunction, which is associated with reduced nitric oxide synthase (NOS) 3 activity (15, 16). PubMed:28314763

Appears in Networks:
Annotations
Text Location
Introduction

path(MESH:Hyperlipidemias) increases path(HM:"Endothelial dysfunction") View Subject | View Object

Endothelial dysfunction, a condition associated with reduced bioavailability of 282 vascular NO, occurs in humans and mice with hyperlipidemia (16). PubMed:28314763

Appears in Networks:
Annotations
Text Location
Introduction

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.